Moderna kicks off mRNA cancer vaccine study; Biotech stocks were checked this month -- but that's a good thing
→ Moderna has kicked off its Phase I study for a personalized cancer vaccine, with the first dose in patients announced today. The …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
